Avid Bioser­vices to be sold to pri­vate eq­ui­ty firms for $1.1B

Af­ter a year of cus­tomer pull­backs, bi­o­log­ics CD­MO Avid Bioser­vices will be tak­en pri­vate by GHO Cap­i­tal Part­ners and Am­per­sand Cap­i­tal Part­ners in a deal …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.